1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsRare Belonging® is sponsored by Alexion Charitable Foundation (Alexion, AstraZeneca Rare Disease). Rare Belonging® is the signature program of the Alexion Charitable Foundation, partnering with other nonprofits that support individuals, caregivers, and families impacted by rare diseases.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Alexion Charitable Foundation | Alexion Global Site Alexion Charitable Foundation The Alexion Charitable Foundation Bringing promise, hope, and belonging to people affected by rare Addressing Health Disparities in the Rare Disease Community The Alexion Charitable Foundation (ACF) is designed to have the most positive impact possible on the communities we serve.
Our mission is to address the health disparities within and among the rare disease community. We invest in projects to ensure that all underserved communities have equitable pathways to the care, services and resources they need to live healthier lives.
Celebrating Our First Four Years On Rare Disease Day in February of 2020, Alexion, AstraZeneca Rare Disease (Alexion) made a steadfast commitment to the community by launching its charitable giving arm, the Alexion Charitable Foundation.
Extending Alexion's dedication to understanding and serving the needs of people affected by rare diseases, the Foundation was established to bring promise, hope, and belonging to people living with a rare disease and those who care for them.
As we reflect on the Foundation's recent grant making history, we are inspired by the collective impact our charitable partners have had in charting more equitable pathways to the care, services, and resources their community members need to lead fulfilling lives. For more information on ACF’s historical work and partnerships, see our first annual report here .
Rare Belonging® is our signature program where we partner with other nonprofits that support individuals, caregivers, and families impacted by rare disease. Our collective strength and investments allow us to help address some of the most pressing needs of the rare disease community.
Improving the mental health and wellbeing of people living with rare conditions and their caregivers by tackling systemic hurdles to supports, services, and tools. Improving access by reducing barriers and addressing obstacles faced by people living with rare conditions. Empowering people living with rare conditions, their caregivers, and physicians through improved health literacy across the continuum of care.
The Foundation has made a significant impact on the lives of people affected by rare disease.
From 2020-2023, ACF impacted communities around the world through three core grant making programs: Rare Belonging®, its signature initiative supporting individuals, caregivers and families impacted by rare disease; Local Needs, meeting community needs in the areas where Alexion has a major presence; and Emergency Response, funding to offer relief to global communities in the wake of the COVID-19 pandemic.
the year ACF was established, bringing the global rare disease community together to help more people. people reached since 2020 with grants supporting improved healthcare services and resources. charitable partners in 15 countries around the globe.
grants awarded since 2020 to help make a significant impact on the lives of people affected by rare disease. Grant Application Process The Alexion Charitable Foundation provides funding to third party, disease agnostic, nonprofit organizations that design and administer programs aligning with Rare Belonging®'s funding priorities. Prior to applying for a Rare Belonging® grant, please review the Foundation’s Guidelines and Criteria.
Rare Belonging Guidelines and Criteria Medical Education and Patient Advocacy Grants You are now going to another site.
According to the current listing, eligibility includes: Third-party, disease-agnostic, nonprofit organizations that design and administer programs aligning with Rare Belonging®'s funding priorities. Confirm the full requirements in the official notice before applying.
Rare Belonging® is funded by Alexion Charitable Foundation (Alexion, AstraZeneca Rare Disease). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Anthropic is giving rare-disease researchers and early-stage biotechs up to $50,000 in Claude API credits over six months — not cash, but compute. Here is how the two-track program works, who is eligible, what the credits can and cannot do, and how it fits a fast-growing new category: the compute-as-grant model reshaping how AI-for-science actually gets funded.
Read articleThe Department of Energy's Office of Critical Minerals and Energy Innovation is spending to break America's 95% dependence on foreign rare earths. The strategy is unusual: recover critical materials from the waste streams of coal plants, smelters, and refineries that already exist. Here is the full funding architecture — the $75M just awarded, the $500M battery-materials round, the $1B pipeline behind them — and how an industrial operator should position for what comes next.
Read articleOn June 2, 2026, the Department of Energy's Office of Critical Minerals and Energy Innovation selected two demonstration-scale facilities — Phoenix Tailings (with MIT and the University of Minnesota) for $66 million, and the Colorado School of Mines (with ElementUSA, PNNL, Principal Mineral, and Rare Earth Technologies Inc.) for the balance — under the Rare Earth Elements Demonstration Facility Program. Both projects pull rare earths from industrial waste — red mud at the Gramercy refinery in Louisiana, and a mix of mine and refining tailings elsewhere. Here is what the selections tell researchers, small businesses, and downstream magnet customers about where DOE thinks the chokepoint actually is, and what to do before the next demonstration-scale solicitation opens.
Read article